Overview
A catalyst for
medical innovation.
ICORP-Med backs the founders, scientists and operators building the next generation of medical technology and biotech — with long-term capital, clinical rigor and an ecosystem designed for durable impact.
200M+.
Patients treated each year through our portfolio companies.
30+.
Countries deploying medical innovations from our affiliates.
€12M.
Invested in R&D over the past three years.
Our thesis
Conviction, not consensus.
Healthcare is being rebuilt at the intersection of clinical science, software and access. We invest with a founder-first temperament — patient, principled and deeply involved.
We concentrate capital behind a small number of ambitious teams tackling cardiovascular disease, chronic conditions, and the digitisation of care. Each investment is grounded in scientific rigor and validated by our committee of practicing physicians and researchers.
01
Founder-first
We invest early and stay close. Long-term partners, not passengers on the cap table.
02
Scientific rigor
Every thesis is stress-tested by our committee of clinicians and researchers.
03
Patient outcomes
We measure success in lives improved as much as in returns delivered.
04
Durable capital
Responsible, long-horizon capital designed to compound with the companies we back.
The ecosystem
An operating platform, not a passive shareholder.
ICORP-Med carries its vision through active MedTech and BioTech affiliates. This alignment lets our founders move faster: shared research, shared clinical networks, shared standards.
Explore our companiesFor founders
Building something that matters
in health?
We read every note. Tell us about your team, your science and the change you want to see.
Reach the team